BioCentury | Dec 2, 2016
Company News

Heptares, G7 deal

...renamed Heptares Zurich. G7 Therapeutics AG , Zurich, Switzerland Sosei Group Corp. (Tokyo:4565), Tokyo, Japan Business: Pharmaceuticals Shannon Lehnbeuter G7 Therapeutics Heptares...
BioCentury | Dec 19, 2015
Company News

Soland replaces Aldag as uniQure CEO

...to focus on board activities at Molecular Partners AG (SIX:MOLN), where he is chairman, and G7 Therapeutics AG...
BioCentury | Aug 17, 2015
Company News

G7 Therapeutics, MorphoSys deal

...to the targets and antibodies to third parties. The companies declined to provide financial terms. G7 Therapeutics AG...
Items per page:
1 - 3 of 3
BioCentury | Dec 2, 2016
Company News

Heptares, G7 deal

...renamed Heptares Zurich. G7 Therapeutics AG , Zurich, Switzerland Sosei Group Corp. (Tokyo:4565), Tokyo, Japan Business: Pharmaceuticals Shannon Lehnbeuter G7 Therapeutics Heptares...
BioCentury | Dec 19, 2015
Company News

Soland replaces Aldag as uniQure CEO

...to focus on board activities at Molecular Partners AG (SIX:MOLN), where he is chairman, and G7 Therapeutics AG...
BioCentury | Aug 17, 2015
Company News

G7 Therapeutics, MorphoSys deal

...to the targets and antibodies to third parties. The companies declined to provide financial terms. G7 Therapeutics AG...
Items per page:
1 - 3 of 3